Paul Kemp recently attended the annual meeting of BIOtrachea FP7 project in Stockholm.
The BIOtrachea project is managed by the BIOtrachea EU consortium, consisting of 13 EU-based, clinical, academic, and commercial participants, including Intercytex Ltd. The project is partially funded by the European Commission.
To learn more, please visit the BIOtrachea project website at www.biotrachea.eu
|< Prev||Next >|